Dexrazoxane 250 mg/1 (Dexrazoxane INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 250 mg/1

Dexrazoxane 250 mg/1 is a lyophilized powder for solution, used primarily in medical settings. This injectable form is designed for intravenous administration and is manufactured by Hikma Pharmaceuticals USA Inc.

Strength

250 mg/1

Pack Size

1 VIAL in 1 BOX (0143-9247-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dexrazoxane is commonly used in conjunction with certain chemotherapy treatments. It is often administered to reduce the risk of cardiac toxicity associated with specific cancer therapies. The primary use of Dexrazoxane is to protect the heart from damage that can occur during chemotherapy, particularly with anthracycline-based treatments.

Side Effects

When administered as directed, Dexrazoxane may help mitigate the cardiotoxic effects of certain chemotherapy drugs. Patients should be monitored for any adverse reactions, as individual responses to the medication can vary. Common effects may include localized reactions at the injection site.

Precautions & Warnings

Dexrazoxane should be handled and administered by healthcare professionals in a controlled medical environment. It is important to follow proper storage and preparation guidelines to maintain the integrity of the lyophilized powder. Patients with known allergies to any components of Dexrazoxane should avoid its use.

Avoid Interactions

Dexrazoxane may interact with other medications, particularly those metabolized by the liver. It is crucial to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy and safety of Dexrazoxane.

References

Frequently Asked Questions

Dexrazoxane is primarily used to reduce the risk of cardiac toxicity associated with certain chemotherapy treatments, particularly those involving anthracyclines.

Dexrazoxane is administered intravenously as a lyophilized powder that is reconstituted into a solution before use.

Common side effects may include localized reactions at the injection site. Individual responses can vary, and patients should be monitored for any adverse reactions.

Dexrazoxane may interact with other medications, so it is important to inform healthcare providers about all current medications to avoid potential interactions.

Patients with known allergies to any components of Dexrazoxane should avoid its use. Always consult a healthcare professional before starting any new medication.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.